218 related articles for article (PubMed ID: 9495846)
1. The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors.
Bencherif M; Schmitt JD; Bhatti BS; Crooks P; Caldwell WS; Lovette ME; Fowler K; Reeves L; Lippiello PM
J Pharmacol Exp Ther; 1998 Mar; 284(3):886-94. PubMed ID: 9495846
[TBL] [Abstract][Full Text] [Related]
2. RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.
Bencherif M; Lovette ME; Fowler KW; Arrington S; Reeves L; Caldwell WS; Lippiello PM
J Pharmacol Exp Ther; 1996 Dec; 279(3):1413-21. PubMed ID: 8968366
[TBL] [Abstract][Full Text] [Related]
3. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
4. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
[TBL] [Abstract][Full Text] [Related]
5. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
[TBL] [Abstract][Full Text] [Related]
6. A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.
Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Piattoni-Kaplan M; Campbell JE; McKenna DG; Molinari E; Hettinger AM; Garvey DS; Wasicak JT; Holladay MW; Williams M; Arneric SP
Neuropharmacology; 1996 Jun; 35(6):725-34. PubMed ID: 8887981
[TBL] [Abstract][Full Text] [Related]
7. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
8. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
[TBL] [Abstract][Full Text] [Related]
10. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Marks MJ; Meinerz NM; Drago J; Collins AC
Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
[TBL] [Abstract][Full Text] [Related]
12. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
Xiao Y; Kellar KJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
[TBL] [Abstract][Full Text] [Related]
14. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
Carroll FI; Lee JR; Navarro HA; Ma W; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2002 Oct; 45(21):4755-61. PubMed ID: 12361403
[TBL] [Abstract][Full Text] [Related]
16. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
[TBL] [Abstract][Full Text] [Related]
17. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
[TBL] [Abstract][Full Text] [Related]
18. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
Dávila-García MI; Musachio JL; Kellar KJ
J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
[TBL] [Abstract][Full Text] [Related]
19. Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35.
Wenger BW; Bryant DL; Boyd RT; McKay DB
J Pharmacol Exp Ther; 1997 May; 281(2):905-13. PubMed ID: 9152400
[TBL] [Abstract][Full Text] [Related]
20. Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen.
Ogunjirin AE; Fortunak JM; Brown LL; Xiao Y; Dávila-García MI
Neurochem Res; 2015 Oct; 40(10):2131-42. PubMed ID: 26508288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
